While 2025's IPO boom is likely being enjoyed by Wall Street’s investment bankers, it may be even better news for private ...

First-time share sales in the U.S. this year have raised a combined $46.15 billion — excluding blank-check firms — the ...

Jim Boyle, Medline CEO, celebrates with others as medical supplies giant Medline (MDLN) holds it's IPO at Nasdaq stock market ...

Medline shares rose 20.7% in their hotly anticipated New York debut today, valuing the medical supply giant at $46 billion in the largest U.S. initial public offering since Rivian’s 2021 listing, ...

Wall Street is getting a glimpse of what could be the biggest year ever for IPOs in the U.S. After four years of choppiness ...

Medline will debut on the Nasdaq later on Wednesday after the U.S. medical supply giant raised $6.26 billion in the biggest ...

Hashkey Holdings shares slid 3% on debut after raising $206 million via an Initial public offering in Hong Kong.

Despite a U.S. government shutdown that hit the "pause" button on new initial public offerings, the IPO market is expected to finish 2025 as it started, with a flurry of newly minted publicly ...

Medline’s bigger product lineup and strong cash flow gives it a leg up on competitors, according to Jonathan Palmer, a Bloomberg Intelligence health-care analyst, creating a virtuous circle that ...

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's ...

Circle has experienced extreme stock volatility, rising nearly 10x post-IPO before retracing sharply as valuation concerns ...